marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-02-2023
Surface Oncology Financial Ratios 2011-2024 | SURF
Annual Financial Ratios Surface Oncology
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -2.7 | 5.5 | -1.3 | -17.2 | - | - | - | - | - | - | - |
P/S |
1.4 | 78.7 | 2.6 | 4.7 | 1.9 | - | - | - | - | - | - | - |
EPS |
-1.1 | -1.8 | 1.7 | -2.0 | -0.3 | -18.4 | -7.3 | - | - | - | - | - |
EV (Enterprise Value) |
56.3 M | 227 M | 215 M | 101 M | 102 M | 100 M | 76.6 M | - | - | - | - | - |
EBITDA per Share |
-1.08 | -1.68 | 1.78 | -2 | -0.39 | - | - | - | - | - | - | - |
EV/EBITDA |
-2.6 | 2.3 | -0.6 | -4.0 | - | - | - | - | - | - | - | |
PEG |
- | 0.02 | 0.0 | -0.2 | - | - | - | - | - | - | - | |
P/B |
0.4 | 1.8 | 2.1 | 1.3 | 1.1 | - | - | - | - | - | - | - |
P/CF |
-0.7 | -3.4 | 10.9 | -1.2 | -7.5 | - | - | - | - | - | - | - |
ROE % |
-68.08 | -66.01 | 38.10 | -96.69 | -6.41 | - | - | - | - | - | - | - |
ROA % |
-39.76 | -41.12 | 27.33 | -41.60 | -3.79 | - | - | - | - | - | - | - |
ROCE % |
-66.24 | -63.93 | 39.54 | -51.03 | -6.23 | - | - | - | - | - | - | - |
Current Ratio |
2.4 | 2.7 | 3.5 | 5.6 | 6.1 | - | - | - | - | - | - | - |
DSO |
- | - | - | 8.0 | 2.0 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Surface Oncology
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.46 | -0.33 | - | -0.39 | -0.46 | 0.13 | - | -0.44 | -0.44 | -0.37 | 1.66 | -0.39 | -0.44 | 0.81 | -0.57 | -0.61 | -0.64 | -0.15 | -0.17 | -0.62 | -0.73 | 1.59 | -6.16 | -5.75 | -2.73 | -3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.32 | - | -0.37 | -0.45 | 0.15 | - | -0.4 | -0.43 | -0.34 | 1.67 | -0.33 | -0.41 | 0.82 | -0.59 | -0.58 | -0.63 | -0.16 | -0.2 | -0.62 | -0.74 | 11.5 | -6.19 | -5.43 | -2.54 | -3.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-124.56 | -87.29 | -36.44 | -51.60 | -46.16 | -38.93 | -37.76 | 5.48 | 10.51 | 13.82 | 38.10 | -33.30 | -52.96 | -74.79 | -96.69 | -73.14 | -60.09 | -44.17 | -6.41 | 21.62 | 59.76 | 84.94 | 67.41 | 43.98 | 22.58 | 12.81 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-82.71 | -37.15 | -7.10 | -17.65 | -18.25 | -27.48 | -27.03 | 3.99 | 7.27 | 9.69 | 27.33 | -15.80 | -21.36 | -28.02 | -41.60 | -32.21 | -29.29 | -24.91 | -3.79 | -20.43 | -28.22 | -27.19 | -55.71 | -36.34 | -18.66 | -10.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-118.66 | -86.11 | -35.23 | -50.09 | -44.65 | -37.62 | -36.56 | 7.08 | 12.72 | 15.93 | 39.54 | -32.92 | -54.68 | -78.01 | -101.24 | -77.84 | -64.39 | -47.84 | -8.90 | 21.24 | 59.97 | 85.79 | 68.32 | 43.61 | 22.41 | 12.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.9 | 2.2 | 2.4 | 2.6 | - | 3.1 | 2.6 | 3.3 | 3.6 | 3.9 | 3.5 | 3.5 | 3.5 | 3.5 | 1.8 | 1.8 | 1.8 | 1.8 | 2.4 | 2.4 | 2.4 | 2.4 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency